Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients
Year: 2017
Type: article
Study design: Clinical Trial
Authors: Mark Nelson, Rafael Rubio, Adriano Lazzarin, Svetlana Romanova, Annie Luetkemeyer, Brian Conway, Jean-Michel Molina, Dong Xu, Subasree Srinivasan, Simon Portsmouth
Institutions: Chelsea and Westminster Hospital, Hospital Universitario 12 De Octubre, IRCCS Ospedale San Raffaele, Ministry of Health of the Russian Federation, University of California, San Francisco, Vancouver Infectious Diseases Centre, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Université Paris Diderot, Bristol-Myers Squibb (United States), Shionogi (United States)
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Bristol-Myers Squibb
OpenAlex ID: W2588094065